NIA set to build $300M ‘real world’ Alzheimer’s database
By
Alicia Lasek
Apr 06, 2023
The goal is to collect real-world data on Alzheimer’s disease and create a centralized data hub, helping to expand and speed Alzheimer’s research.
NIH highlights decade of Alzheimer’s advancements tied to small business investments
By
Alicia Lasek
Aug 11, 2021
A new paper showcases the results of 11 years of federal investment in dementia research, including advancements in care intervention, diagnostics and therapeutics.
Clinical Briefs for Wednesday, June 26
By
Alicia Lasek
Jun 25, 2019
Drug combo may combat deadly candida auris … Alzheimer’s ‘cabal’ thwarted research progress for decades … Can deprescribing drugs reduce dementia risk? … NIH study: Optimal threshold for diagnosing...
New drug therapy may ease sleep disruptions due to Alzheimer’s
By
Alicia Lasek
Jul 24, 2019
A new drug has shown promise for regulating sleep in people with mild to moderate Alzheimer’s disease.
Alzheimer’s blood test to be used in memory-loss prevention trial
By
Alicia Lasek
Nov 12, 2021
The PrecivityAD blood test will lower barriers to participation in a new clinical trial that aims to prevent the symptoms of Alzheimer’s disease, researchers say.
FDA advisers object to Alzheimer’s drug aducanumab ahead of final decision
By
Alicia Lasek
Apr 05, 2021
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.